Mounjaro Price Drop Could Transform Irish Health

Ireland’s drug watchdog is poised to approve a major price cut for Mounjaro, potentially slashing the cost burden on the state after Eli Lilly’s new offer. Just months ago, the HSE warned of a five-billion-euro overspend, leading to outright rejection — but now, with a revised price tag of two to three billion euros over five years, the NCPE may finally see value. Experts hail this as a turning point for public health, with obesity specialist Donal O’Shea calling it transformative — though he warns that long-term savings remain invisible, making upfront investment a tough sell for any health system. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/867c4b6422564815